Tumor multifocality and serum albumin levels can identify groups of patients with hepatocellular carcinoma and portal vein thrombosis having distinct survival outcomes

Carr, B.; Guerra, V; Donghia, R.; Yilmaz, SEZAİ

doi:10.1016/j.amsu.2021.102458

Tumor multifocality and serum albumin levels can identify groups of patients with hepatocellular carcinoma and portal vein thrombosis having distinct survival outcomes

Atıf İçin Kopyala

Carr B., Guerra V., Donghia R., Yilmaz S.

ANNALS OF MEDICINE AND SURGERY, cilt.66, 2021 (ESCI)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 66
Basım Tarihi: 2021
Doi Numarası: 10.1016/j.amsu.2021.102458
Dergi Adı: ANNALS OF MEDICINE AND SURGERY
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
İnönü Üniversitesi Adresli: Evet

Özet

Background: Macroscopic portal vein thrombosis (PVT) is a major poor prognosis factor in patients with hepatocellular carcinoma (HCC), but constitute a heterogeneous group.